文献速递肝病消化道肿瘤与早癌

年龄与性别对乙型肝炎表面抗原清除后肝细胞癌风险的影响

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
PubMed 文献 · J Hepatol · 2017-06-24

该研究纳入香港医院管理局2000年1月至2016年8月间HBsAg清除的慢性乙型肝炎患者4568例,中位随访3.4年,54例发生肝细胞癌(HCC)。年龄>50岁(调整HR 4.31)和男性(HR 2.47)是HCC独立危险因素;≤50岁女性5年内HCC风险为零,>50岁女性和所有男性仍有风险。

要点

  • HBsAg清除后年龄>50岁(调整HR 4.31,95%CI 1.72-10.84)和男性(HR 2.47,95%CI 1.24-4.91)是HCC独立危险因素。
  • ≤50岁女性(n=545)随访5年内HCC风险为零。
  • ≤50岁男性、>50岁女性、>50岁男性5年HCC累积发生率分别为0.7%、1.0%、2.5%。

核心结论

  • ≤50岁女性在HBsAg清除后HCC风险为零,而>50岁女性和所有男性仍有HCC风险。

研究设计与样本

  • 研究纳入香港医院管理局2000年1月至2016年8月期间接受医疗照护且HBsAg清除的所有慢性乙型肝炎患者,共4568例;其中793例(17.4%)接受核苷(酸)类似物治疗,60例(1.3%)接受干扰素治疗。

主要发现

  • 中位随访3.4年(四分位距1.5-5.0年)期间,54例患者发生HCC;1年、3年和5年HCC累积发生率分别为0.9%、1.3%和1.5%。
  • 年龄>50岁(调整HR 4.31,95%CI 1.72-10.84;p=0.002)和男性(HR 2.47,95%CI 1.24-4.91;p=0.01)是HCC的两个独立危险因素。
  • ≤50岁女性(n=545)随访5年内HCC风险为零;≤50岁男性(n=769)、>50岁女性(n=1149)和>50岁男性(n=2105)的5年HCC累积发生率分别为0.7%、1.0%和2.5%。
  • 在自发性HBsAg清除和抗病毒治疗诱导的HBsAg清除患者中观察到相似结果。

临床怎么用

  • 作者指出,≤50岁女性在HBsAg清除后HCC风险为零,而>50岁女性和所有男性仍有HCC风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Previous studies suggested spontaneous seroclearance of hepatitis B surface antigen (HBsAg) was still associated with an increased risk of hepatocellular carcinoma (HCC), in patients ⩾50years of age. This study aimed to evaluate the risk of HCC after HBsAg seroclearance and the impact of gender on HCC. METHODS: All chronic hepatitis B patients under medical care in Hospital Authority, Hong Kong who had cleared HBsAg between January 2000 and August 2016 were identified. The age of the patient at HBsAg seroclearance, gender, and subsequent development of HCC were analyzed. RESULTS: A total of 4,568 patients with HBsAg seroclearance were identified; 793 (17.4%) were treated by nucleos(t)ide analogues and 60 (1.3%) had received interferon treatment. At a median (interquartile range) follow-up of 3.4 (1.5-5.0)years, 54 patients developed HCC; cumulative incidences of HCC at 1, 3 and 5years were 0.9%, 1.3% and 1.5%, respectively. Age above 50years (adjusted hazard ratio 4.31, 95% confidence interval 1.72-10.84; p=0.002) and male gender (2.47, 1.24-4.91; p=0.01) were two independent risk factors of HCC. Female patients aged ⩽50years (n=545) had zero risk of HCC within 5years of follow-up. Male patients aged ⩽50years (n=769), female patients aged >50years (n=1,149) and male patients aged >50years (n=2,105) had a 5-year cumulative incidence of HCC 0.7%, 1.0% and 2.5%, respectively. Similar findings were observed in patients with spontaneous and antiviral treatment-induced HBsAg seroclearance. CONCLUSIONS: Female patients aged 50years or below have zero risk of HCC after HBsAg seroclearance, whereas female patients aged above 50years and all male patients are still at risk of HCC. Lay summary: We investigated 4,568 patients with hepatitis B surface antigen (HBsAg) seroclearance. Female patients aged 50years or below have zero risk of hepatocellular carcinoma (HCC) after HBsAg seroclearance, whereas female patients aged above 50years and all male patients are still at risk of HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Yip TC, Chan HL, Wong VW, et al. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2017. PMID: 28652084. doi:10.1016/j.jhep.2017.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。